Impact Of Low Infliximab Dose Regimen On Treatment Response and Drug Survival In 462 Patients With Psoriatic Arthritis: Results From The Nationwide Registries Danbio and Icebio

Bente Glintborg, Bjorn Gudbjornsson, Niels Steen Krogh, Emina Omerovic, Natalia Manilo, Mette Holland-Fischer, Hanne M. Lindegaard, Anne Gitte Loft, Henrik Nordin, Laura Johnsen, Sussi Flejsborg Oeftiger, Annette Hansen, Claus Rasmussen, Gerdur Grondal, Arni Jon Geirsson, Merete Lund Hetland

Research output: Contribution to conference without publisher/journalPosterResearchpeer-review

Original languageEnglish
Publication date2013
Publication statusPublished - 2013
EventAnnual Meeting of American College of Rheumatology, ACR, and Association of Rheumatology Health Professionals, ARHP - San Diego, CA, United States
Duration: 25 Oct 201330 Oct 2013
Conference number: 77, 48

Conference

ConferenceAnnual Meeting of American College of Rheumatology, ACR, and Association of Rheumatology Health Professionals, ARHP
Number77, 48
Country/TerritoryUnited States
CitySan Diego, CA
Period25/10/201330/10/2013

Cite this